Progress in the treatment of autoimmune hemolytic anemia
shao zong hong ; zheng meng ying ;

..............page:855-860

Hemolytic anemia: complement mediated red cell destruction
gao qing zuo ; zhang feng kui ;

..............page:861-865

ICSH recommendations for diagnosis of hereditary red cell membrane disorders and research status of related methodology
li jin ying ; qian bao hua ; cha zhan shan ; jiang zuo zuo ;

..............page:866-870

Optimized choice of treatment regimen for acquired aplastic anemia——stem-cell transplantation from an alternative donor should be used in patients who lack an identical sibling donor
xu lan ping ;

..............page:871-873+876

The choice of immunosuppressive therapy in the treatment of aplastic anemia
he guang sheng ;

..............page:874-876

Analysis of risk factors for children with moderate and severe iron deficiency anemia
WU Tingting;HU Ying;LIU Aiguo;ZHANG Liuqing;HU Qun;LIU Shuangyou;Department of Pediatrics;Tongji Hospital;Tongji Medical College;Huazhong University of Science and Technology;

..............page:877-879

Clinical efficacy of domestic decitabine monotherapy in elder patients with myelodysplastic syndrome
HUANG Qin;LI Yan;WANG Xiaomin;LIU Hong;AN Li;Department of Hematology;Xinjiang Uygur Autonomous Region People’s Hospital;

..............page:880-882

Clinical effect of dasatinib in treatment of imatinib-resistant chronic myeloid leukemia blast crisis
ZHONG Lihong;DU Xin;QIU Chuanghua;CAI Yun;ZHANG Qiaoxia;LOU Jin;LI Ming;Shenzhen Second People’s Hospital;

..............page:883-886

Clinical observation of fertility circumstance among patients with chronic granulocytic leukemia treated with imatinib
GUI Ruirui;ZHANG Gongli;LI Zhen;ZHAO Huifang;ZU Yingling;LI Mengjuan;SONG Yongping;Department of Hematology;the Affiliated Cancer Hospital of Zhengzhou University;Henan Cancer Hospital;

..............page:887-890

Effect of amifostine combine with decltabine and CHG regimen on high-risk myelodysplastic syndrome
ZHOU Wenjin;SHI Yuejian;ZHENG Cuiping;HU Yingying;Department of Hematology;Wenzhou Central Hospital;

..............page:891-893

Clinical analysis of 304 patients with primary extranodal lymphoma
YANG Xige;YANG Xigui;MENG Liang;CHANG Jing;JIANG Chao;Department of Internal Medicine Oncology;Shandong Cancer Hospital;Shandong Academy of Medical Sciences;Wenshang County People’s Hospital in Shandong Province;Department of Internal Medicine Oncology;the Affiliated Hospital of Shandong Academy of Medical Sciences;

..............page:894-897+901

Dasatinib of China Tai-tianqing as second line treatment for chronic myelogenous leukemia in chronic phase
KONG Jun;FU Haixia;LAI Yueyun;SHI Hongxia;QIN Yazhen;HUANG Xiaojun;JIANG Hao;Institute of Hematology;Peking University People’s Hospital;

..............page:898-901

The clinical efficacy of different doses of decitabine to treat myelodysplastic syndrome
SUN Shuxiang;ZHAO Hongguo;XU Hong;WU Ying;CUI Zhongguang;LIU Shanjiao;Department of Hematology;the Affiliated Hospital of Qingdao University Medical College;

..............page:902-904

Clinical observation on therapeutic regimen of relapsed and refractory multiple myeloma based on lenalidomide and dexamethasone
gao shun ji ; sun yan hua ; li guang lun ; guo zhen qing ; zhao hong guo ;

..............page:905-907

Therapeutic strategy for patients with refractory chronic myeloid leukemia( CML)-blast crisis with T315I point mutation——HHT combined with TKI for patients with CML-BC with T315I mutation: two cases report and literature review
he guo min ; chen zuo ; xu juan ; cai ya yun ; zuo hai xiang ;

..............page:908-911

Clinical observation of Pegaspargase and L-asparaginase in the treatment of adult acute lymphoblastic leukemia
zhou yang ; liu yan fang ; wang meng ; wang chong ; xu yan ; sun hui ; wan ding ming ; xie xin sheng ; jiang zhong xing ; sun ling ; ma jie ; guo rong ;

..............page:912-914

A case of the t(8;21) acute myeloid leukemia like as chronic myelomonocytic leukemia and literature review
ye xiu peng ; bao shen ; wei yu ping ; zhi feng ; li ye qiong ; bai jie ; li fang ; jin li yuan ;

..............page:915-917

Mandibular langerhans cell tissue hyperplasia: a case report and literature review
ma zuo ; wang li na ; li zhuo ; mou xiao li ; lv ying ; li zuo ; jia ming feng ; li zi jian ; xi ya ming ;

..............page:918-920

A case of the primary plasma cell leukemia with a large pleural effusion as the first manifestation and literature review
li ye qiong ; bao shen ; ye xiu peng ;

..............page:920-922

The treatment interpretation of Chinese guideline for the diagnosis and treatment of multiple myeloma (2015 edition)
geng chuan ying ; chen wen ming ;

..............page:923-926

Progress of the impact of cytokines in bone marrow microenvironment on multiple myeloma bone disease
liu zhao yun ; fu rong ;

..............page:927-931

The abnormalities and clinical significance of Tregs in patients with aplastic anemia
zhou qiao lin ; zou xing li ; wei jin ;

..............page:932-934

lin chuang xue ye xue za zhi 2016 nian di 29 juan zong mu ci

..............page:935-938